三生制药(01530.HK)获汇添富基金增持209.2万股
3SBIO3SBIO(HK:01530) Ge Long Hui·2025-09-07 23:23

Group 1 - The core point of the news is that Huatai Fund Management Co., Ltd. increased its stake in Sihuan Pharmaceutical (01530.HK) by purchasing 2.092 million shares at an average price of HKD 31.18 per share, totaling approximately HKD 65.23 million [1] - Following this transaction, Huatai Fund's total shareholding in Sihuan Pharmaceutical rose to 122,265,500 shares, increasing its ownership percentage from 4.94% to 5.03% [1][3]